当前位置: X-MOL 学术Congenit. Heart Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test
Congenital Heart Disease ( IF 0.3 ) Pub Date : 2019-08-01 , DOI: 10.1111/chd.12831
Alexander Lemmer 1 , Lisa VanWagner 1, 2 , Zaira Gasanova 3 , Steve Helmke 4, 5 , Gregory T Everson 4, 5 , Daniel Ganger 1
Affiliation  

Fontan surgery for single ventricle congenital heart disease leads to Fontan-associated liver disease (FALD). Typical laboratory tests, imaging, and histopathology cannot predict clinical severity in FALD. HepQuant SHUNT is a proprietary serum test of hepatic function and physiology that has not yet been evaluated in FALD.

中文翻译:

使用 HepQuant SHUNT 测试评估 Fontan 相关肝病的肝功能损害

单心室先天性心脏病的 Fontan 手术导致 Fontan 相关肝病 (FALD)。典型的实验室检查、影像学和组织病理学无法预测 FALD 的临床严重程度。HepQuant SHUNT 是一种专有的肝功能和生理学血清测试,尚未在 FALD 中进行评估。
更新日期:2019-08-01
down
wechat
bug